Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
CHA University
Bayer
CHA University
Pfizer
Sun Yat-sen University
Hunan Cancer Hospital
Hunan Cancer Hospital
Massachusetts General Hospital
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Yonsei University
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Azienda Ospedaliero, Universitaria Pisana
Hoffmann-La Roche
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
Hoffmann-La Roche
ARCAGY/ GINECO GROUP
Hoffmann-La Roche
Technische Universität Dresden
GlaxoSmithKline
University of Rome Tor Vergata
Stanford University
Azienda Ospedaliero, Universitaria Pisana